Hypertrophic Cardiomyopathy

Early Mild Hypertrophic Cardiomyopathy May Still Carry Significant Cardiovascular Risk

This entry was posted in Cardiovascular Diseases and tagged Hypertrophic Cardiomyopathy Natural History Prognosis on

Approximately 21% of patients with phenotypically mild hypertrophic cardiomyopathy (HCM) experienced major adverse cardiovascular events (MACE) during a mean follow-up of seven years, highlighting that even apparently mild disease requires careful long-term monitoring. In this prospective analysis of 2,500 patients from the Sarcomeric Human Cardiomyopathy Registry, 21% developed MACE, including […]

Hypertrophic Cardiomyopathy Guidelines Updated

This entry was posted in Cardiovascular Diseases and tagged Guideline Hypertrophic Cardiomyopathy on

The US guideline for the management of hypertrophic cardiomyopathy (HCM) have been updated. The top 10 take-home messages are: Shared decision-making is essential to provide the best clinical care. Referral to multidisciplinary HCM centers with appropriate expertise can be important to optimizing care for patients with HCM. Careful ascertainment of […]